financetom
Business
financetom
/
Business
/
F5 Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Shares Jump After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
F5 Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Shares Jump After Hours
Jul 30, 2025 2:34 PM

05:09 PM EDT, 07/30/2025 (MT Newswires) -- F5 (FFIV) reported fiscal Q3 non-GAAP earnings late Wednesday of $4.16 per diluted share, up from $3.36 a year earlier.

Analysts polled by FactSet expected $3.51.

Revenue in the three months ended June 30 rose to $780.4 million from $695.5 million a year earlier.

Analysts surveyed by FactSet expected $753.9 million.

The company expects fiscal Q4 non-GAAP EPS of $3.87 to $3.99 on revenue of $780 million to $800 million. Analysts expected EPS of $3.84 on revenue of $777.7 million.

F5 projects full-year revenue growth of 9% at the midpoint, up from 6.5% to 7.5% previously, and non-GAAP EPS growth of 14% to 15%, up from 8% to 10%.

Shares of the company jumped 9.3% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Meta Platforms Threads Reportedly Major Beneficiary of Recent Exodus by Former X Users
Meta Platforms Threads Reportedly Major Beneficiary of Recent Exodus by Former X Users
Nov 26, 2024
04:01 PM EST, 11/26/2024 (MT Newswires) -- Meta Platforms' ( META ) Threads has been adding millions of new users in recent weeks as many internet denizens look for alternatives to X/Twitter since the US elections, multiple media outlets reported Tuesday. Threads has added around 35 million new users during November, including about 20 million people starting accounts on the...
Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline
Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline
Nov 26, 2024
04:00 PM EST, 11/26/2024 (MT Newswires) -- Shares of Amgen ( AMGN ) fell on Tuesday after the biotech company reported results for a phase 2 study of its obesity injection, which fell short of efficacy expectations, Mizuho Securities said. Amgen ( AMGN ) announced that its investigational drug, MariTide, demonstrated up to 20% average weight loss over a 52-week...
Graphic Packaging Holding Insider Sold Shares Worth $355,800, According to a Recent SEC Filing
Graphic Packaging Holding Insider Sold Shares Worth $355,800, According to a Recent SEC Filing
Nov 26, 2024
04:04 PM EST, 11/26/2024 (MT Newswires) -- Charles D Lischer, Senior Vice President and Chief Accounting Officer, on November 25, 2024, sold 12,000 shares in Graphic Packaging Holding ( GPK ) for $355,800. Following the Form 4 filing with the SEC, Lischer has control over a total of 49,849 shares of the company, with 49,849 shares held directly. SEC Filing:...
State Street Insider Sold Shares Worth $1,224,625, According to a Recent SEC Filing
State Street Insider Sold Shares Worth $1,224,625, According to a Recent SEC Filing
Nov 26, 2024
04:05 PM EST, 11/26/2024 (MT Newswires) -- Kathryn M Horgan, Executive Vice President, on November 25, 2024, sold 12,500 shares in State Street (STT) for $1,224,625. Following the Form 4 filing with the SEC, Horgan has control over a total of 111,042 shares of the company, with 111,042 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/93751/000009375124000981/xslF345X05/wk-form4_1732654741.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved